Skip to main content
. 2021 Oct 29;12(11):1026. doi: 10.1038/s41419-021-04310-6

Fig. 6. MYH9761-768 immunization exacerbates EAE disease course.

Fig. 6

C57BL/6 mice were immunized with 100 µg MOG35-55, admixed with OVA257-264 (n = 10) or with MYH9761-768 (n = 9), and received 200 ng B. pertussis Toxin (PTX) i.p. at days 0 and 2. A EAE score and changes in body weight were monitored. *P < 0.05, **P < 0.01, by Mann–Whitney test. B, C Mice were sacrificed at day 29 and flow cytometry analysis was performed in spleens (SPL) and central nervous system (CNS). B Percentages of total CD4+ and CD8+ T cells (upper panels), and of CD44+ CD4+ or CD8+ T cells (lower panels), in the CNS of mice immunized with MOG35-55 plus OVA257-264 (blue) or plus MYH9761-768 (red). *P < 0.05, by Mann–Whitney test. C Percentages of T naïve (TN), T virtual memory (TVM), and T memory (TM) in gated CD8+ T cells from SPL or CNS of mice immunized with MOG35-55 plus OVA257-264 or plus MYH9761-768. The data are from a single experiment representative of two independent experiments. Bars represent means ± SEM.